Müller-Holzner E - Search Results

1

DNA methylation in serum and tumors of cervical cancer patients.

Widschwendter A, Müller HM, Fiegl H, Ivarsson L, Wiedemair A, Müller-Holzner E, Goebel G, Marth C, Widschwendter M. Widschwendter A, et al. Clin Cancer Res. 2004 Jan 15;10(2):565-71. doi: 10.1158/1078-0432.ccr-0825-03. Clin Cancer Res. 2004. PMID: 14760078

2

Human papillomavirus DNA in sera of cervical cancer patients as tumor marker.

Widschwendter A, Blassnig A, Wiedemair A, Müller-Holzner E, Müller HM, Marth C. Widschwendter A, et al. Cancer Lett. 2003 Dec 30;202(2):231-9. doi: 10.1016/j.canlet.2003.09.006. Cancer Lett. 2003. PMID: 14643453

3

CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients.

Widschwendter A, Ivarsson L, Blassnig A, Müller HM, Fiegl H, Wiedemair A, Müller-Holzner E, Goebel G, Marth C, Widschwendter M. Widschwendter A, et al. Int J Cancer. 2004 Mar 20;109(2):163-6. doi: 10.1002/ijc.11706. Int J Cancer. 2004. PMID: 14750164

4

A DNA methylation pattern similar to normal tissue is associated with better prognosis in human cervical cancer.

Müller HM, Widschwendter A, Fiegl H, Goebel G, Wiedemair A, Müller-Holzner E, Marth C, Widschwendter M. Müller HM, et al. Cancer Lett. 2004 Jun 25;209(2):231-6. doi: 10.1016/j.canlet.2003.12.016. Cancer Lett. 2004. PMID: 15159026

5

Analysis of aberrant DNA methylation and human papillomavirus DNA in cervicovaginal specimens to detect invasive cervical cancer and its precursors.

Widschwendter A, Gattringer C, Ivarsson L, Fiegl H, Schneitter A, Ramoni A, Müller HM, Wiedemair A, Jerabek S, Müller-Holzner E, Goebel G, Marth C, Widschwendter M. Widschwendter A, et al. Clin Cancer Res. 2004 May 15;10(10):3396-400. doi: 10.1158/1078-0432.CCR-03-0143. Clin Cancer Res. 2004. PMID: 15161694

6

Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen.

Widschwendter M, Siegmund KD, Müller HM, Fiegl H, Marth C, Müller-Holzner E, Jones PA, Laird PW. Widschwendter M, et al. Cancer Res. 2004 Jun 1;64(11):3807-13. doi: 10.1158/0008-5472.CAN-03-3852. Cancer Res. 2004. PMID: 15172987

7

DNA hypomethylation and ovarian cancer biology.

Widschwendter M, Jiang G, Woods C, Müller HM, Fiegl H, Goebel G, Marth C, Müller-Holzner E, Zeimet AG, Laird PW, Ehrlich M. Widschwendter M, et al. Cancer Res. 2004 Jul 1;64(13):4472-80. doi: 10.1158/0008-5472.CAN-04-0238. Cancer Res. 2004. PMID: 15231656

8

Analysis of methylated genes in peritoneal fluids of ovarian cancer patients: a new prognostic tool.

Müller HM, Millinger S, Fiegl H, Goebel G, Ivarsson L, Widschwendter A, Müller-Holzner E, Marth C, Widschwendter M. Müller HM, et al. Clin Chem. 2004 Nov;50(11):2171-3. doi: 10.1373/clinchem.2004.034090. Clin Chem. 2004. PMID: 15502091 No abstract available.

9

The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.

Wolf D, Wolf AM, Rumpold H, Fiegl H, Zeimet AG, Muller-Holzner E, Deibl M, Gastl G, Gunsilius E, Marth C. Wolf D, et al. Clin Cancer Res. 2005 Dec 1;11(23):8326-31. doi: 10.1158/1078-0432.CCR-05-1244. Clin Cancer Res. 2005. PMID: 16322292

10

Breast cancer DNA methylation profiles in cancer cells and tumor stroma: association with HER-2/neu status in primary breast cancer.

Fiegl H, Millinger S, Goebel G, Müller-Holzner E, Marth C, Laird PW, Widschwendter M. Fiegl H, et al. Cancer Res. 2006 Jan 1;66(1):29-33. doi: 10.1158/0008-5472.CAN-05-2508. Cancer Res. 2006. PMID: 16397211

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters